Stephen J. Hoffman, Director at ALLOS THERAPEUTICS INC (ALTH), sold 116,285 shares at $6.54 ($776K) on 2010-01-04, disclosed to the SEC on 2010-01-06.
Scheduled sale ($776k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.54 | 25,428 | $166K | 21.4% |
| 2 | $6.64 | 45,428 | $302K | 38.9% |
| 3 | $6.78 | 45,429 | $308K | 39.7% |
| Total | $6.67 avg | 116,285 | $776K | 100% |
| Filing → |
| GNCA | BUY | 2014-02-11 | $3.0M | — | Filing → |
| DRNA | BUY | 2014-02-05 | $3.0M | — | Filing → |
| ACRX | BUY | 2012-05-31 | $968K | — | Filing → |